Thursday, July 30, 2020
Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing
Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Dream, co-founded by ex-NSO Group CEO Shalev Hulio with a focus on protecting critical infrastructure, raised $260M at a $3B valuation, up from $1B in 2025 (Galit Altstein/Bloomberg)
Galit Altstein / Bloomberg : Dream, co-founded by ex-NSO Group CEO Shalev Hulio with a focus on protecting critical infrastructure, raise...
-
Sohee Kim / Bloomberg : South Korean authorities are investigating a data leak at e-commerce giant Coupang that exposed ~33.7M accounts; ...
-
The first project we remember working on together was drawing scenes from the picture books that our mom brought with her when she immigrate...
No comments:
Post a Comment